A carregar...
替吉奥治疗晚期非小细胞肺癌三线及以上患者的疗效分析
BACKGROUND AND OBJECTIVE: There is no standard treatment for advanced non-small cell lung cancer (NSCLC) after the failure of two lines of chemotherapy, S-1 as the third generation of fluorouracil derivate with well safety and low toxicity, presented some efficacy in lung cancer treatment. The aim o...
Na minha lista:
| Publicado no: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
中国肺癌杂志编辑部
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6022025/ https://ncbi.nlm.nih.gov/pubmed/29945701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2018.06.03 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|